lactic acid has been researched along with etoposide in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 13 (56.52) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Schaefer, MJ; Singh, J | 3 |
| Kylmä, J; Nazhat, SN; Rich, J; Seppälä, J; Tanner, KE; Tuominen, J | 1 |
| De, S; Miller, DW; Robinson, DH | 1 |
| Murthy, RS; Reddy, LH; Vivek, K | 1 |
| Ardenkjaer-Larsen, JH; Brindle, KM; Day, SE; Gallagher, FA; Golman, K; Hu, DE; Kettunen, MI; Lerche, M; Wolber, J | 1 |
| Babbar, AK; Saha, RN; Sharma, RK; Snehalatha, M; Venugopal, K | 1 |
| Sawant, KK; Yadav, KS | 1 |
| Harilal, A; Krishnakumar, S; Maheswari, UK; Mitra, M; Mohanty, C; Sahoo, SK | 1 |
| Andry, MC; Callewaert, M; Dukic, S; Gafa, V; Molinari, M; Roullin, VG; Van Gulick, L; Vittier, M | 1 |
| Abbasian, Z; Dadashzadeh, S; Saadati, R; Soleimanjahi, H | 1 |
| Allhenn, D; Béduneau, A; Lamprecht, A; Neumann, D; Pellequer, Y | 1 |
| Feng, R; Huang, G; Li, Z; Zhang, Z | 1 |
| Clarke, PA; Grundy, RG; Langmack, KA; Macarthur, DC; Morgan, PS; Rahman, CV; Ritchie, AA; Rose, FR; Shakesheff, KM; Smith, SJ | 1 |
| Fatma, S; Goswami, DG; Iqbal, Z; Negi, LM; Panda, AK; Talegaonkar, S; Tariq, M | 1 |
| Baj-Rossi, C; Carrara, S; Cavallini, A; De Micheli, G; Ghoreishizadeh, SS | 1 |
| Chen, YC; Kuo, YC | 1 |
| Wang, B; Xu, M; Xu, SF; Yu, XC | 1 |
| da Silva, GR; da Silva-Cunha, A; de Faria, LGA; de Fátima Pereira, A; de Oliveira Patricio, PS; Fialho, SL; Fulgêncio, GO; Pianetti, GA; Solano, AGR | 1 |
| Li, S; Li, Z; Liu, S; Wang, Z; Zhao, F | 1 |
1 review(s) available for lactic acid and etoposide
| Article | Year |
|---|---|
Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
Topics: Antineoplastic Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Evaluation, Preclinical; Etoposide; Lactic Acid; Microscopy, Electron, Scanning; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; X-Ray Diffraction | 2010 |
22 other study(ies) available for lactic acid and etoposide
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Effect of additives on stability of etoposide in PLGA microspheres.
Topics: Antineoplastic Agents, Phytogenic; Biocompatible Materials; Chromatography, High Pressure Liquid; Drug Stability; Etoposide; Lactic Acid; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Temperature; Time Factors | 2001 |
Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres.
Topics: Biocompatible Materials; Delayed-Action Preparations; Etoposide; Kinetics; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Time Factors; Triglycerides | 2002 |
Lactic acid based PEU/HA and PEU/BCP composites: Dynamic mechanical characterization of hydrolysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Substitutes; Cisplatin; Composite Resins; Etoposide; Gamma Rays; Hydrolysis; Lactic Acid; Materials Testing; Mechanics; Mitoxantrone; Polyesters; Polyurethanes; Sodium Chloride; Sterilization; Tamoxifen | 2002 |
Effect of isopropyl myristic acid ester on the physical characteristics and in vitro release of etoposide from PLGA microspheres.
Topics: Delayed-Action Preparations; Drug Compounding; Esters; Etoposide; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Myristates; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2000 |
Effect of particle size of nanospheres and microspheres on the cellular-association and cytotoxicity of paclitaxel in 4T1 cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Boron Compounds; Brain; Cattle; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Cyclosporine; Deoxyglucose; Drug Screening Assays, Antitumor; Endocytosis; Endothelium, Vascular; Etoposide; Lactic Acid; Microspheres; Nanotubes; Paclitaxel; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers | 2005 |
Comparative study of some biodegradable polymers on the entrapment efficiency and release behavior of etoposide from microspheres.
Topics: Absorbable Implants; Antineoplastic Agents, Phytogenic; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Drug Compounding; Drug Implants; Electrolytes; Etoposide; Kinetics; Lactic Acid; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polyvinyl Alcohol; Solubility | 2007 |
Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carbon Isotopes; Cell Death; Cell Line, Tumor; Etoposide; Lactate Dehydrogenases; Lactic Acid; Lymphoma; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Neoplasm Transplantation; Pyruvic Acid | 2007 |
Etoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99m.
Topics: Animals; Antineoplastic Agents, Phytogenic; Area Under Curve; Biological Availability; Drug Compounding; Drug Delivery Systems; Drug Stability; Etoposide; Injections, Intravenous; Isotope Labeling; Lactic Acid; Male; Mice; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2008 |
A novel in vitro three-dimensional retinoblastoma model for evaluating chemotherapeutic drugs.
Topics: Antineoplastic Agents; Biocompatible Materials; Carboplatin; Cell Culture Techniques; Cell Proliferation; Cell Survival; Diffusion; Doxorubicin; Etoposide; Extracellular Matrix; Gene Expression Profiling; Humans; Inhibitory Concentration 50; Kinetics; Lactic Acid; MicroRNAs; Nanoparticles; Oligonucleotide Array Sequence Analysis; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Porosity; Retinoblastoma; Tissue Engineering; Tissue Scaffolds | 2012 |
Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Carriers; Etoposide; Glioma; Humans; Lactic Acid; Mice; Monocytes; Nanoparticles; Particle Size; Poloxamer; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Surface Properties | 2013 |
Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug.
Topics: Animals; Antibodies; Antineoplastic Agents, Phytogenic; Drug Carriers; Etoposide; Immunoglobulin M; Injections, Intravenous; Lactic Acid; Male; Nanoparticles; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar | 2013 |
A "drug cocktail" delivered by microspheres for the local treatment of rat glioblastoma.
Topics: Acridines; Animals; Antineoplastic Agents, Phytogenic; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Carriers; Etoposide; Glioblastoma; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazoles; Rats; Rats, Inbred F344; Sulfonamides; Tetrahydroisoquinolines | 2013 |
Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
Topics: Administration, Inhalation; Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Etoposide; Kinetics; Lactic Acid; Microspheres; Models, Chemical; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Surface Properties; Technology, Pharmaceutical | 2014 |
Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix.
Topics: Animals; Brain Neoplasms; Cell Death; Cell Line, Tumor; Chemotherapy, Adjuvant; Drug Delivery Systems; Etoposide; Humans; Lactic Acid; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sheep; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2013 |
Novel flavonoid-based biodegradable nanoparticles for effective oral delivery of etoposide by P-glycoprotein modulation: an in vitro, ex vivo and in vivo investigations.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; Biological Availability; Breast Neoplasms; Cell Separation; Cell Survival; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Etoposide; Female; Flow Cytometry; Fluorescent Dyes; Humans; Inhibitory Concentration 50; Intestinal Absorption; Lactic Acid; Male; MCF-7 Cells; Microscopy, Confocal; Nanoparticles; Nanotechnology; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Quercetin; Rats, Wistar; Rhodamines; Solubility; Sonication; Technology, Pharmaceutical | 2016 |
An integrated control and readout circuit for implantable multi-target electrochemical biosensing.
Topics: Antineoplastic Agents, Phytogenic; Biosensing Techniques; Electrochemical Techniques; Electrodes, Implanted; Etoposide; Glucose; Humans; Lactic Acid | 2014 |
Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
Topics: Antineoplastic Agents, Phytogenic; Astrocytes; Blood-Brain Barrier; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cells, Cultured; Drug Delivery Systems; Endothelial Cells; Etoposide; Folate Receptors, GPI-Anchored; Folic Acid; Glioblastoma; Humans; Lactic Acid; Lactoferrin; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Cell Surface; Topoisomerase II Inhibitors | 2015 |
Paclitaxel and etoposide co-loaded polymeric nanoparticles for the effective combination therapy against human osteosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Line, Tumor; Drug Carriers; Etoposide; Humans; Lactic Acid; Nanoparticles; Osteosarcoma; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2015 |
Etoposide-Loaded Poly(Lactic-co-Glycolic Acid) Intravitreal Implants: In Vitro and In Vivo Evaluation.
Topics: Animals; Chickens; Drug Implants; Etoposide; Intravitreal Injections; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Vitreous Body | 2018 |
Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Erlotinib Hydrochloride; Etoposide; Gefitinib; Humans; Immunologic Factors; Immunotherapy; Lactic Acid; Lung Neoplasms; Prognosis; Reproducibility of Results; Tumor Microenvironment | 2022 |